ANI Pharmaceuticals Inc ANIP
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $65.43
- Day Range
- $64.29–65.28
- 52-Week Range
- $36.99–70.81
- Bid/Ask
- $61.80 / $79.00
- Market Cap
- $1.36 Bil
- Volume/Avg
- 82,928 / 149,955
Key Statistics
- Price/Earnings (Normalized)
- 13.86
- Price/Sales
- 2.45
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
ANI Pharmaceuticals Inc develops, manufactures, and markets generic prescription pharmaceuticals. It manufactures liquid, powder, and oral solid dose products. Its areas of product development include narcotics, oncolytic, hormones and steroids, and complex formulations involving extended release and combination products. Some of its generic products include Erythromycin ethyl succinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Fluvoxamine, Hydrocortisone Enema and Vancomycin. Its geographical segments are the United States and Canada, of which the majority of its revenue comes from the United States.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Growth
- Total Number of Employees
- 642
Comparables
Valuation
|
Metric
|
ANIP
|
SCLX
|
016580
|
|---|---|---|---|
Price/Earnings (Normalized) | 13.86 | — | 7.11 |
Price/Book Value | 3.09 | — | 0.59 |
Price/Sales | 2.45 | 2.65 | 0.92 |
Price/Cash Flow | 12.65 | — | 5.43 |
Price/Earnings
ANIP
SCLX
016580
Financial Strength
|
Metric
|
ANIP
|
SCLX
|
016580
|
|---|---|---|---|
Quick Ratio | 2.63 | 0.15 | 3.93 |
Current Ratio | 3.57 | 0.19 | 5.30 |
Interest Coverage | 1.74 | −106.04 | 1,345.19 |
Quick Ratio
ANIP
SCLX
016580
Profitability
|
Metric
|
ANIP
|
SCLX
|
016580
|
|---|---|---|---|
Return on Assets (Normalized) | 10.25% | −106.47% | 7.92% |
Return on Equity (Normalized) | 22.54% | — | 8.87% |
Return on Invested Capital (Normalized) | 16.08% | −1,960.39% | 7.89% |
Return on Assets
ANIP
SCLX
016580
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
MKKGY
| Merck KGaA ADR | Pjzpcjtb | Tvvltw | $70.9 Bil | |
ZTS
| Zoetis Inc Class A | Dqtsqwgjrh | Bnvn | $68.9 Bil | |
HLN
| Haleon PLC ADR | Ktzsvvsvy | Qwgxj | $37.5 Bil | |
TEVA
| Teva Pharmaceutical Industries Ltd ADR | Blfsrndk | Kpj | $14.7 Bil | |
VTRS
| Viatris Inc | Ckqptvph | Nkv | $13.7 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Pkrylwbsb | Khqp | $11.9 Bil | |
CTLT
| Catalent Inc | Hknptzdn | Rbyxj | $10.1 Bil | |
PRGO
| Perrigo Co PLC | Tgdmwfqjb | Tvnx | $4.1 Bil | |
CURLF
| Curaleaf Holdings Inc | Hbjdgwxhh | Mwxct | $3.6 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Drkzjnqd | Sxbzzmc | $3.5 Bil |